BACKGROUND: Muscle weakness and wasting are known manifestations of hypercortisolism (HC). Central sarcopenia is a marker of frailty and predicts mortality. The hypothesis of this study is that central sarcopenia can be used as a marker of disease severity and frailty in patients with HC. METHODS: Psoas muscle area and psoas muscle density (PMD) were measured at specific points on CT scans of patients with HC using a defined protocol. We compared 24-hour urine cortisol (24HUC) levels by time point to each CT scan. A linear regression model was used to describe the relationship between 24HUC and morphometric variables. A comparison with matched non-HC patients was performed. RESULTS: We identified 45 patients (34 female). The median age was 46 years (range, 14-80); the median 24HUC was 211 mg/dL (range, 9.5-39,500); the median PMD was 50.1 24HUC (range, 20-72). An inverse correlation (-0.29) between 24HUC levels and PMD was noted (P = .045). Intra-abdominal fat was also significantly and positively correlated with 24HUC: 27 non-HC patients matched for age, sex, and body-mass index showed higher (58 vs 51) PMD (P = .0127) compared to those with HC. CONCLUSION: PMD and intra-abdominal fat are significantly related to 24HUC levels. Morphometric measures of the overall burden of HC may allow more precise assessment of disease severity.
BACKGROUND:Muscle weakness and wasting are known manifestations of hypercortisolism (HC). Central sarcopenia is a marker of frailty and predicts mortality. The hypothesis of this study is that central sarcopenia can be used as a marker of disease severity and frailty in patients with HC. METHODS: Psoas muscle area and psoas muscle density (PMD) were measured at specific points on CT scans of patients with HC using a defined protocol. We compared 24-hour urine cortisol (24HUC) levels by time point to each CT scan. A linear regression model was used to describe the relationship between 24HUC and morphometric variables. A comparison with matched non-HC patients was performed. RESULTS: We identified 45 patients (34 female). The median age was 46 years (range, 14-80); the median 24HUC was 211 mg/dL (range, 9.5-39,500); the median PMD was 50.1 24HUC (range, 20-72). An inverse correlation (-0.29) between 24HUC levels and PMD was noted (P = .045). Intra-abdominal fat was also significantly and positively correlated with 24HUC: 27 non-HC patients matched for age, sex, and body-mass index showed higher (58 vs 51) PMD (P = .0127) compared to those with HC. CONCLUSION:PMD and intra-abdominal fat are significantly related to 24HUC levels. Morphometric measures of the overall burden of HC may allow more precise assessment of disease severity.
Authors: Barbra S Miller; Kathleen M Ignatoski; Stephanie Daignault; Ceit Lindland; Megan Doherty; Paul G Gauger; Gary D Hammer; Stewart C Wang; Gerard M Doherty Journal: World J Surg Date: 2012-07 Impact factor: 3.352
Authors: John Tapper; Grace Huang; Karol M Pencina; Zhuoying Li; Stefan Arver; Anna Martling; Lennart Blomqvist; Christian Buchli; Thomas G Travison; Thomas W Storer; Shalender Bhasin; Shehzad Basaria Journal: Menopause Date: 2019-12 Impact factor: 2.953
Authors: Carlos H Martinez; Alejandro A Diaz; Catherine A Meldrum; Merry-Lynn N McDonald; Susan Murray; Gregory L Kinney; John E Hokanson; Jeffrey L Curtis; Russell P Bowler; MeiLan K Han; George R Washko; Elizabeth A Regan Journal: Ann Am Thorac Soc Date: 2017-11
Authors: Ryan W Stidham; Akbar K Waljee; Nicholas M Day; Carrie L Bergmans; Katelin M Zahn; Peter D R Higgins; Stewart C Wang; Grace L Su Journal: Inflamm Bowel Dis Date: 2015-06 Impact factor: 5.325